In contrast, another study reported MT’s positive outcomes in TNBS (trinitrobenzene sulfonic acid)—induced colitis in mice are mediated by the inhibition of inflammation through the down-regulation of the TLR4/Myeloid differentiation primary response 88 (MyD88)/NF-κB pathway [154]. The gene discussed is TLR4; the disease is colitis.